Development of LAG-3/FGL1 blocking peptide and combination with radiotherapy for cancer immunotherapy

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (U20A20369)
  • Science, Technology and Innovation Commission of Shenzhen Municipality (KQTD20190929173853397)
  • Basic and Applied Basic Research Foundation of Guangdong Province (2022B1515120085)

This publication has 59 references indexed in Scilit: